Keymed Biosciences Inc. (HKG:2162)
Hong Kong · Delayed Price · Currency is HKD 72.50
-0.35 (-0.48%)
Nov 10, 2026, 4:08 PM HKT
Keymed Biosciences Market Cap
Keymed Biosciences has a market cap or net worth of 21.36 billion as of November 9, 2026. It is the 5,422nd most valuable company in the world and the 275th biggest in Hong Kong. Its market cap has increased by 26.09% in one year.
Market Cap
21.36B
Enterprise Value
18.44B
Revenue
963.56M
Global Rank
Country Rank
#275 Hong Kong
PE Ratio
23.14
ChartMarket Cap Chart
Since July 8, 2021, Keymed Biosciences's market cap has increased from 18.43B to 21.36B, an increase of 15.90%. That is a compound annual growth rate of 2.80%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 10, 2026 | 21.36B | 35.64% |
| Dec 31, 2025 | 15.75B | 84.90% |
| Dec 31, 2024 | 8.52B | -37.32% |
| Dec 29, 2023 | 13.59B | -4.15% |
| Dec 30, 2022 | 14.17B | 46.87% |
| Dec 31, 2021 | 9.65B | -47.63% |
| Jul 8, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| 3SBio | 37.73B |
| Biocytogen Pharmaceuticals (Beijing) | 35.69B |
| Shanghai Junshi Biosciences | 32.04B |
| Shanghai Henlius Biotech | 27.48B |
| InnoCare Pharma | 25.94B |
| Zai Lab | 25.52B |
| InSilico Medicine Cayman TopCo | 22.24B |
| Metis TechBio | 13.23B |